comparemela.com

Latest Breaking News On - தைரோகேர் தொழில்நுட்பங்கள் லிமிடெட் - Page 2 : comparemela.com

PharmEasy-Thyrocare deal: This is the right time and right way to exit, A Velumani says

It was the right time and right way to exit, Thyrocare s A Velumani says PharmEasy is not an individual-run business but an institution, Thyrocare s founder A Velumani says, adding that he sees a lot of similarities between both the companies. Synopsis Arokiaswamy Velumani, who quit a government job at the Bhabha Atomic Research Centre to start Thyrocare in 1995, on why he decided to sell his company to PharmEasy and what he plans to do next. Bengaluru | Kolkata: Arokiaswamy Velumani, promoter of Thyrocare Technologies Ltd., never once regretted quitting his job as a scientist at the Bhabha Atomic Research Centre in 1995, fascinated as he was by the success of entrepreneurs. Had he stayed on, Velumani who was earning about Rs 5,000 a month then would have retired this year, but the entrepreneurial urge beckoned and there was no looking back.

Markets likely to open on a flat note - The Hindu BusinessLine

Markets likely to open on a flat note June 28, 2021 Consolidation phase likely to continue, say analysts Domestic markets are expected to open the new week on a positive-to-flat note amid mixed global cues. Market experts said the market would largely remain in a consolidation phase before taking a clear direction. The SGX Nifty is currently ruling at 15,900 indicates (8 am) against the July futures at 15,888, and the spot close of 15,860.95. Last week, the US markets closed with a mixed tone, with tech-focussed Nasdaq slipping marginally even as the Dow Jones Industrial Average and the broader S&P 500 closed higher, with the latter hitting a record high on Friday.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.